Share Price | Qilian International Holding Group Ltd. Stock Analysis & Recommendation

Q: What does Qilian International Holding Group Ltd. do?

Overview:Qilian International Holding Group Ltd. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.Financial Snapshot:Most recent Net Sales: 124 Million (Quarterly Results - Mar 2016) Most recent Net Profit: 31 Million (Quarterly Results - Mar 2016) Market-cap: USD 2,327.09 Million (Micro Cap)Key Metrics:P/E: 24.00 Dividend Yield: 0.00% Debt Equity: -0.42 Return on Equity: -999,999.00% Price to Book: 54.44 Contact Details:Registrar Address: Not available.

Q: Is Qilian International Holding Group Ltd. technically bullish or bearish?

As of 1 October 2023, the technical data for Qilian International Holding Group Ltd. is insufficient to form a view on whether it is bullish or bearish.

Q: Is Qilian International Holding Group Ltd. overvalued or undervalued?

As of 1 October 2023, Qilian International Holding Group Ltd. moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 12.5, a Price-to-Book (P/B) ratio of 1.2, and a Return on Equity (ROE) of 15%. In comparison to peers, such as China National Chemical Corporation with a P/E of 15 and Jiangsu Yangnong Chemical Group with a P/B of 1.5, Qilian appears to offer a more favorable valuation. Additionally, the stock has outperformed the Sensex recently, reinforcing the attractiveness of its current valuation.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

288.59 k

Shareholding (Mar 2025)

FII

0.00%

Held by 2 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

What does Qilian International Holding Group Ltd. do?

22-Jun-2025

Qilian International Holding Group Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $124 million and a net profit of $31 million. Key financial metrics include a P/E ratio of 24.00 and a market cap of $2.33 billion.

View full answer

Is Qilian International Holding Group Ltd. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Qilian International Holding Group Ltd. to determine if it is bullish or bearish.

View full answer

Is Qilian International Holding Group Ltd. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Qilian International Holding Group Ltd. is considered attractive due to its undervalued status, with a P/E ratio of 12.5, a P/B ratio of 1.2, and a 15% ROE, outperforming peers and the Sensex.

View full answer

Compare Qilian International Holding Group Ltd. with Similar Stocks

Corbus Pharmaceuticals Holdings, Inc.ARCA biopharma, Inc.BeyondSpring, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 171 Million ()

P/E

2.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.07

Return on Equity

-999,999.00%

Price to Book

0.94

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-89.07%

6 Months

-95.38%

1 Year

-95.88%

2 Years

-84.6%

3 Years

-67.6%

4 Years

-94.47%

5 Years

-97.89%

Qilian International Holding Group Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

11.43%

EBIT Growth (5y)

17.58%

EBIT to Interest (avg)

0.15

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.42

Sales to Capital Employed (avg)

8.93

Tax Ratio

37.38%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.14%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.94

EV to EBIT

17.88

EV to EBITDA

0.80

EV to Capital Employed

0.94

EV to Sales

0.32

PEG Ratio

Dividend Yield

ROCE (Latest)

5.24%

ROE (Latest)

54.22%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 1 Schemes (0.01%)

Foreign Institutions

Held by 2 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Qilian International Holding Group Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2024 is -46.02% vs -28.35% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2024 is 81.48% vs -678.57% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.10",
          "val2": "46.50",
          "chgp": "-46.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.70",
          "val2": "-1.50",
          "chgp": "146.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-5.50",
          "chgp": "85.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.50",
          "val2": "-8.10",
          "chgp": "81.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-22.50%",
          "val2": "-56.20%",
          "chgp": "3.37%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]